Answers are grounded in this paper and cite their sources.
This study elucidates interactions between polyethylene terephthalate microplastics (PETMPs) and the blood–brain barrier, investigates their regulatory effects on key Alzheimer’s disease (AD)-related proteins, and evaluates PETMP-induced neurodegenerative risks using an interdisciplinary validation approach. We developed a tetra-dimensional framework integrating computational toxicology, systems pharmacology, genetic epidemiology, and molecular simulation. Disease-related targets (n=15,929) were sourced from DisGeNET, GeneCards, and OMIM. PET-interacting proteins (n=326) were predicted via SEA, PharmMapper, and SwissTargetPrediction. Intersection analysis identified 184 overlapping targets. Topological characterization of protein–protein interaction networks using Cytoscape revealed key mediators. Bidirectional Mendelian randomization with GWAS datasets validated target-AD correlations through inverse variance weighted (IVW) estimates, confirmed via pleiotropy-robust analyses. Molecular recognition patterns were determined using AutoDock Vina scoring. Force field parameters were acquired using Gromacs’ pdb2gmx utility and AutoFF. Genetic colocalization confirmed causal links with tissue specificity. ADMET predictions suggest that PET exhibit significant potential to penetrate the blood–brain barrier. Molecular docking experiments revealed strong interactions between PET and core Alzheimer’s disease targets, with the PET-JAK2 complex exhibiting the highest binding affinity. Molecular dynamics simulations further confirmed that the PET-JAK2 complex reached equilibrium within 5ns, indicating structural stability. Mendelian randomization analysis established a causal association between JAK2 genetic variants and Alzheimer’s disease risk. Collectively, these findings elucidate a molecular mechanism wherein PET first penetrate the blood–brain barrier. They then bind with high affinity to targets like JAK2, activating neuroinflammatory pathways to increase Alzheimer’s disease risk.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: